GLP-1 prices for October 2026: what changed
2026-09-30 · Updated Nov 17, 2026 · 11 min read · GLPcompare Editorial
Lowest prices now

Lowest compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Lowest compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
The newest reports are GLP-1 prices for November 2026 and compounded semaglutide and tirzepatide prices in November 2026. They have every current lowest price and what changed since this one.
Today's lowest GLP-1 prices
This table is computed from current prices each time this page is read, so it is newer than the October report below, which keeps the prices as we found them then. GLPcompare now tracks 1,322 self-pay prices from 522 US sellers, each read on the seller's own page and dated. Compounded medications are not FDA-approved.
| What you are buying | Lowest price now | Who charges it |
|---|---|---|
| FDA-approved, starting dose | $149 per 30 days | Foundayo (LillyDirect self-pay) at LillyDirect (Eli Lilly) (from $149/mo); Ozempic tablets at NovoCare (Novo Nordisk) ($149/30 days); and 6 more. Every FDA-approved price |
| FDA-approved injection, starting dose | $213 per 30 days | Ozempic pen at NovoCare (Novo Nordisk) ($199/fill initially, offer through Dec 31, 2026); Wegovy pen (standard doses 0.25-2.4 mg) at NovoCare (Novo Nordisk) ($199/fill initially, offer through Dec 31, 2026); and 2 more. Every injection price |
| FDA-approved injection, top dose | $372 per 30 days | Generic liraglutide 3 mg pens (Saxenda generic), GoodRx coupon at GoodRx (~$372/mo). Prices by dose |
| Compounded semaglutide (not FDA-approved) | about $76 a month over a year with the membership | Compounded semaglutide at Collective ($59/mo + $199/yr membership). All 462 sellers |
| Compounded semaglutide at 2.4 mg (not FDA-approved) | about $76 a month over a year with the membership | Compounded semaglutide at Collective ($59/mo + $199/yr membership). Prices at 2.4 mg |
| Compounded tirzepatide (not FDA-approved) | about $86 a month over a year with the membership | Compounded tirzepatide at Collective ($69/mo + $199/yr membership). All 451 sellers |
| Compounded tirzepatide at 15 mg (not FDA-approved) | about $86 a month over a year with the membership | Compounded tirzepatide at Collective ($69/mo + $199/yr membership). Prices at 15 mg |
| Compounded liraglutide (not FDA-approved) | $179 a month | Compounded liraglutide at Henry Meds ($179/mo). All 9 sellers |
Every current price, compounded tirzepatide prices and compounded semaglutide prices are ranked the same way.
The October 2026 report
Short answer: the lowest FDA-approved self-pay prices in the US are still $149 for 30 days at a starting dose (Wegovy pill 1.5 mg, Ozempic tablets 1.5 mg, Foundayo 0.8 mg). At the doses people usually stay on, the lowest is $299 for 30 days (Wegovy pill 25 mg, Ozempic tablets 9 mg, Foundayo 17.2 mg with an on-time refill). Manufacturer prices did not change this month. Compounded and telehealth prices did, and several advertised prices were not what they looked like.
We checked every quote below on the seller's own page on September 30, 2026. Each one links to that page. Prices change often, so confirm the amount due, the dose and any membership fee with the seller before you order. This is price information, not medical advice.
Update, October 27, 2026. GLPcompare now tracks 194 self-pay prices from 76 sellers (58 when this report was written), each read on the seller's own page between October 15 and October 24. The lowest FDA-approved starting price is still $149 for 30 days. The lowest compounded prices that state the supply they buy are now:
- Compounded tirzepatide: about $129 per 30 days at Affinity Direct ($120.14 every 28 days on a 3-month auto-refill plan).
- Compounded semaglutide: $99 per 30 days for Strut Health's oral lozenge, which Strut now prescribes only when a commercially available GLP-1 is not an option for you.
Compounded products are not FDA-approved. New since this report: which sellers charge no membership fee, which take an HSA or FSA and which take insurance. The November report has what changed since, and the price comparison has every current price.
Update, October 13, 2026. We rechecked all 58 quotes on the sellers' own pages. Manufacturer prices are unchanged. Since this report:
- Sprout Health now advertises $149 (semaglutide) and $199 (tirzepatide) every 4 weeks on its homepage, while an older product page still lists $299 and $349, so confirm the amount at checkout.
- CoreAge Rx lowered its starting prices to $79 (semaglutide) and $129 (tirzepatide) a month.
- Gala now lists semaglutide from $129 a month on a yearly plan; tirzepatide is still from $179.
- Wellorithm now publishes its prices: $247 a month for semaglutide and $349 for tirzepatide, after a first month of $147 or $249.
- Ozari's $86 and $125 plans are now an ongoing quarterly plan (Ozari One, $258 or $375 every 3 months, not offered in California), not a starter plan for first-time patients.
- AgelessRx's microdosing tirzepatide is $109 for the first month, then $209 a month billed every 2 months.
- GoodRx coupons: generic exenatide fell to about $422 a pen; generic liraglutide (Victoza) is about $144 for its most common 3-pen carton.
- Correction: Found's 12-month plans are billed every 28 days, not paid upfront as this report first said.
Current prices for every seller are on the price comparison.
Manufacturer prices: unchanged
Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect) sell FDA-approved GLP-1s directly to self-pay patients. Every price we track from both was the same on September 30 as on our previous check.
| Medication | Starting price | Price at the top dose |
|---|---|---|
| Wegovy pill (oral semaglutide) | $149 / 30 days (1.5 mg) | $299 / 30 days (9 mg and 25 mg) |
| Wegovy pen | $199 per fill for a new patient's first two fills of 0.25 or 0.5 mg | $349 / 28 days (up to 2.4 mg); Wegovy HD 7.2 mg $399 |
| Ozempic tablets | $149 / 30 days (1.5 mg) | $299 / 30 days (9 mg) |
| Ozempic pen | $199 per fill for the first two fills | $349 (0.25 to 1 mg) or $499 (2 mg) / 28 days |
| Zepbound vials or KwikPen | $299 / 28 days (2.5 mg) | $449 / 28 days (7.5 to 15 mg) with a refill within 45 days, otherwise $499 or $699 |
| Foundayo (orforglipron pill) | $149 / 30 days (0.8 mg) | $299 / 30 days (14.5 and 17.2 mg) with a refill within 45 days, otherwise $349 |
| Mounjaro | from $499 / 28 days, every strength | from $499 / 28 days |
| Trulicity | from $389 / 28 days, every strength | from $389 / 28 days |
Two details matter when you compare these. A box of four weekly pens is a 28-day supply, not a calendar month, so $349 for 28 days is about $374 for 30 days. And Lilly's lower Zepbound and Foundayo prices at the higher doses depend on refilling within 45 days.
The numbers
| Price per 30 days | |
|---|---|
| Foundayo 17.2 mg | $299 |
| Wegovy pill 25 mg | $299 |
| Ozempic tablets 9 mg | $299 |
| Wegovy pen 2.4 mg | $374 |
| Trulicity 4.5 mg | $417 |
| Wegovy HD 7.2 mg | $428 |
| Zepbound 15 mg | $481 |
| Ozempic pen 2 mg | $535 |
| Mounjaro 15 mg | $535 |
Deadlines to know: the Wegovy pill's $149 promotion on the 4 mg dose ended August 31, so 4 mg is now $199. NovoCare's $199 introductory fills need a prescription written and received by December 31, 2026. Foundayo's temporary prices ($149 for 2.5 mg, $199 for 5.5 mg) also run through December 31, 2026.
Compounded and telehealth: what changed
Compounded semaglutide and tirzepatide are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Since the FDA declared the shortages over, these are limited to patient-specific prescriptions, and on September 18 the FDA sent a warning letter to Empower Pharmacy (fda.gov), a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide. For a detailed breakdown of the legal mechanics and safety factors, read our guide to compounded GLP-1 FDA rules and real costs. The prices below are what the sellers advertise.
| Seller | What changed |
|---|---|
| Eden | Compounded tirzepatide is now a flat $129 a month at every dose, with no membership fee (our September 3 record showed $249 for the first month, then $329). |
| Mochi Health | Medication now starts at $60 for semaglutide and $90 for tirzepatide, priced by dose, plus the $79 monthly membership (about $139 and $169 a month at the lowest doses). |
| Noom | After $129 for the first 4 weeks, compounded semaglutide is $279 a month, billed $837 every 12 weeks (new accounts since July). |
| Strut Health | Injectable tirzepatide is $149 per 30-day supply with auto-refill (was $199). Strut now prescribes compounded GLP-1s only when a commercial GLP-1 is not an option for the patient. |
| Gala | Compounded semaglutide and tirzepatide start at $179 a month on a yearly plan, $199 on a 3-month plan. |
| Found | Now publishes product prices: semaglutide from $169 and tirzepatide from $239 per 28 days on a 12-month plan paid upfront, or $289 and $359 month to month. |
Advertised prices that were not what they looked like
Some headline prices did not move, but a closer read of the seller's own terms changes what they mean. We now show each one with its real terms.
- Sprout Health: "from $149" and "from $199" are the first month after $150 off. The subscription then renews at $299 (semaglutide) or $349 (tirzepatide) every 4 weeks.
- Ozari: $86 (semaglutide) and $125 (tirzepatide) are a one-time 3-month starter plan for first-time GLP-1 patients, paid upfront ($257 and $375). After that, semaglutide is $145 a month on a quarterly plan or $175 month to month.
- HealthRX: $99 (semaglutide) and $179 (tirzepatide) a month require a 12-month plan billed upfront ($1,188 and $2,148).
- Wellorithm: the $147 and $249 prices quoted by review sites are first-month prices after a discount. Wellorithm shows its compounded prices only inside its online intake, so we no longer list a number for it.
- AgelessRx: $139 a month is the starting price of its whole GLP-1 program on a 4-month plan, not a semaglutide price.
Other changes that affect what you can buy
- Rybelsus is being replaced by Ozempic tablets. Novo Nordisk told the FDA it is discontinuing all Rybelsus strengths (3, 7 and 14 mg), replaced by Ozempic tablets (1.5, 4 and 9 mg), which launched in May (prnewswire.com) at $149, $199 and $299. The doses are not interchangeable milligram for milligram. See the semaglutide page for the FDA notices.
- Brand Saxenda is leaving the US. Novo Nordisk expects its last shipments to wholesalers in late January 2027. Generic liraglutide at the same 3 mg dose is sold by several manufacturers; GoodRx lists it from about $372 per carton of five pens.
- TrumpRx is a pharmacy coupon for Novo Nordisk medicines. For Wegovy, the Wegovy pill and Ozempic, TrumpRx shows a discount coupon to use at a retail pharmacy at Novo's self-pay prices; it does not sell or dispense drugs. Zepbound vials still route to LillyDirect.
- Medicare. The Medicare GLP-1 Bridge (cms.gov) caps the copay at $50 a month for eligible Part D enrollees through December 31, 2027, for Foundayo, the Wegovy pen and pill, and the Zepbound KwikPen. Who qualifies and how to get it is in our Medicare GLP-1 Bridge guide. Medicare's negotiated semaglutide prices (cms.gov) take effect January 1, 2027.
- Insurance. CVS Caremark says it is adding Zepbound back as a preferred option (cvshealth.com) on its commercial formularies from October 1, 2026.
How we check prices
We check every self-pay quote on the seller's own page and record the date on each one; a quote not rechecked within 21 days is shown as overdue and left out of price rankings. On September 30 we confirmed 54 of the 58 quotes we track. Ro's and Hims' pages block automated checks, so their September 26 checks stand. Prices for 28-day supplies are converted to 30 days so they can be compared, and a first-month discount never stands in for the ongoing price. Some provider links on GLPcompare are referral links; they never change a price. The full rules are on our methodology page.
Compare the options
- Every self-pay offer, sorted by price
- Wegovy vs Zepbound: price, trial results and the head-to-head SURMOUNT-5 trial
- Semaglutide vs tirzepatide
- Foundayo (orforglipron), the newest GLP-1 pill
- Compounded GLP-1 FDA rules & real costs
- All providers
We publish these changes each month. Prices on the comparison pages update as soon as we recheck them.